Metabolic Health

Topics

Browse all topics A-Z Browse all research areas A-Z
Showing 1-4 of 4

Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC): An add-on project to “Duke University CMS Innovation Award Southeastern Diabetes Initiative”

This study leverages the existing research resources of a funded parent project “Duke University Centers for Medicare and Medicaid Services (CMS) Innovation Award Southeastern Diabetes initiative (PI: Robert M. Califf, MD).” It explores the feasibility of implementing Screening for substance use, Brief Intervention, and Referral to Treatment services (SBIRT) in diabetic patients in primary care, and examines the effects of substance use status on diabetes health care outcomes.

Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD)

Accelerating Alzheimer's Research and Drug Development

The Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD) is a precompetitive partnership among government, industry, and nonprofit organizations to transform the current model for developing new diagnostics and treatments for Alzheimer's disease.

Accelerating Medicines Partnership (AMP)

Scientific Contacts for AMP AD

Laurie Ryan, Ph.D.
Email Laurie Ryan

Advancing Health Research through Multimodal AI

Background

Multimodal AI has the potential to capture the complexity of biomedical and behavioral systems and improve clinical decision‑making, but realizing this promise requires new innovations in data fusion, model training, evaluation, and application. Ethical considerations—including privacy, fairness, accountability, and transparency—must be integrated throughout the entire lifecycle, from data selection and preparation to model deployment, with careful attention to stakeholder needs.